SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-028366
Filing Date
2024-05-31
Accepted
2024-05-31 16:21:44
Documents
17
Period of Report
2024-05-31
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20030354_8k.htm   iXBRL 8-K 35682
2 EXHIBIT 99.1 ef20030354_ex99-1.htm EX-99.1 39330
6 image00026.jpg GRAPHIC 3267
7 image00027.jpg GRAPHIC 3265
8 image00028.jpg GRAPHIC 3410
  Complete submission text file 0001140361-24-028366.txt   240712

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA imcr-20240531.xsd EX-101.SCH 3874
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE imcr-20240531_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imcr-20240531_pre.xml EX-101.PRE 16050
20 EXTRACTED XBRL INSTANCE DOCUMENT ef20030354_8k_htm.xml XML 4442
Mailing Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY
Business Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY 01235 5430281
Immunocore Holdings plc (Filer) CIK: 0001671927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39992 | Film No.: 241010061
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)